Latest news
CAPR Stock Gains Steam: Former Capricor Exec Could Become FDA’s Top Gene Therapy Regulator Ahead Of High-Stakes DMD Decision - StocktwitsStocktwits · Fri, 07 Aug 2026 04:56:51 GMTCAPR Stock Surged 17% Today — What’s Fueling The Rally? - StocktwitsStocktwits · Wed, 05 Aug 2026 13:33:46 GMTCAPR Stock Drop: Capricor Therapeutics Clinical Data Leads to 64% Stock Drop and Securities Fraud Class Action for Investors - morningstar.commorningstar.com · Tue, 04 Aug 2026 15:36:00 GMTCAPR Stock On Track For Worst Week Ever After Regulatory Setback For DMD Therapy - StocktwitsStocktwits · Fri, 31 Jul 2026 07:00:00 GMTCapricor Therapeutics (CAPR) Falls On FDA Doubts, Where Does Fair Value Sit? - simplywall.stsimplywall.st · Wed, 29 Jul 2026 15:20:48 GMTThis Analyst Slashed CAPR Stock’s Target By 86% – But, Retail Bulls Say Setup Offers An Attractive Risk-Reward - StocktwitsStocktwits · Tue, 28 Jul 2026 07:00:00 GMTCAPR Stock On Track For Worst Day Ever — Analysts Divided On Deramiocel’s Approval Probability After FDA Documents Paint ‘Ugly Picture’ - TradingViewTradingView · Mon, 27 Jul 2026 19:42:12 GMTCAPR Stock Is Crashing Today – FDA Briefing Casts Doubt On Duchenne Cell Therapy Before Key Vote - finance.yahoo.comfinance.yahoo.com · Mon, 27 Jul 2026 07:00:00 GMT